Copyright
©The Author(s) 2016.
World J Hepatol. Apr 8, 2016; 8(10): 471-484
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.471
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.471
Variable | NMR | MS |
Sensitivity | Lower than MS (nanomolar) | Higher than NMR (picomolar) |
Sample degradation | No | Yes |
Reproducibility | High | Moderate |
Metabolite identification | Well categorized | Labor intensive |
Serum marker | Sensitivity | Specificity |
AFP | 39%-65% | 79%-94% |
AFP-L3 | 75%-97% | 90%-92% |
DCP | 48%-62% | 81%-98% |
AFU | 82% | 71%-85% |
AFP-L3 + DCP | 85% | 98% |
- Citation: Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol 2016; 8(10): 471-484
- URL: https://www.wjgnet.com/1948-5182/full/v8/i10/471.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i10.471